To include your compound in the COVID-19 Resource Center, submit it here.

Knock in to knock out

Kinases are often part of a complex and adaptable cell signaling network, which makes target validation challenging. Cellular Genomics Inc. believes it can speed up kinase target validation using its analog sensitive kinase allele (ASKA) knock-in mice. Serono S.A. last week signed a deal with CGI to use the technology in its drug discovery.

CGI (Branford, Conn.) uses chemical genetics to make

Read the full 611 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers